Bioscience Animal Health PCL (BKK:BIS)

Market Cap	640.56M -26.6%
Revenue (ttm)	2.25B -3.0%
Net Income	38.47M -40.8%
EPS	0.12 -40.8%
Shares Out	314.00M
PE Ratio	16.65
Forward PE	n/a
Dividend	0.12 (5.88%)
Ex-Dividend Date	Apr 29, 2026

Volume	1,802
Average Volume	97,157
Open	2.040
Previous Close	2.040
Day's Range	2.040 - 2.040
52-Week Range	1.700 - 3.120
Beta	0.72
RSI	53.06
Earnings Date	Feb 27, 2026

About BKK:BIS

Bioscience Animal Health Public Company Limited manufactures, imports, and distributes pharmaceutical supplies, devices, and equipment in Thailand. The company offers bioscience products, such as antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. In addition, the company provides farm production consultant; disease prevention and monitoring; serological diagnostic; farm biosecurity and sanitati...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2004
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BIS

Financial Performance

In 2025, BKK:BIS's revenue was 2.25 billion, a decrease of -3.01% compared to the previous year's 2.32 billion. Earnings were 38.47 million, a decrease of -40.85%.